Corvus Pharmaceuticals Inc (NASDAQ:CRVS)

5.70
Delayed Data
As of Jan 17
 +0.32 / +5.95%
Today’s Change
2.53
Today|||52-Week Range
8.10
+4.78%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Orbimed Advisors Llc
Director
Buy6/28/2019565,178$3.72$2.1M+52.41%
Orbimed Advisors Llc
Director
Buy6/28/2019565,178$3.72$2.1M+52.41%
Orbimed Advisors Llc
Director
Buy7/01/201959,243$3.91$231.6K+37.35%
Orbimed Advisors Llc
Director
Buy7/01/201959,243$3.91$231.6K+37.35%
Orbimed Advisors Llc
Director
Buy6/27/201932,923$3.34$110.0K+68.14%
Orbimed Advisors Llc
Director
Buy6/27/201932,923$3.34$110.0K+68.14%
Lea Leiv
Chief Financial Officer
Buy6/06/201915,500$3.56$55.2K+66.67%
Miller Richard A /vantage/
President & Chief Executive Officer
Buy11/13/201914,736$3.00$44.2K+94.54%
Miller Richard A /vantage/
President & Chief Executive Officer
Buy6/14/201911,657$3.40$39.6K+68.64%
Lea Leiv
Chief Financial Officer
Buy6/07/201910,000$3.38$33.8K+67.16%
Page of 2